The iron chelator deferoxamine has been reported to inhibit both xanthine oxidase (XO) and xanthine dehydrogenase (XDH) activity, but the relationship of this effect to the availability of iron in the cellular and tissue environment remains unexplored. XO and total xanthine oxidoreductase activity in cultured V79 cells was increased with exposure to ferric ammonium sulfate and inhibited by deferoxamine. Lung XO and total xanthine oxidoreductase activities were reduced in rats fed an iron-depleted diet and increased in rats supplemented with iron, without change in the ratio of XO to total oxidoreductase. Intratracheal injection of an iron salt or silica-iron, but not aluminum salts or silica-zinc, significantly increased rat lung XO and total xanthine oxidoreductase activities, immunoreactive xanthine oxidoreductase and the concentration of urate in bronchoalveolar fluid. These results suggest the possibility that the production of uric acid, a major chelator of iron in extracellular fluid, is directly influenced by iron-mediated regulation of the expression and/or activity of its enzymatic source, xanthine oxidase.
INTRODUCTION
As Homo sapiens has evolved, our species has lost uricase activity, acquired efficient renal tubular reabsorption of urate, and as a consequence developed plasma urate concentrations that are ten-fold higher in man than most other mammals (42) . Teleologically, these events have been explained as necessary for man to utilize urate as an antioxidant and have been cited as a possible basis for increases in both human lifespan and brain size (2) . In addition to functioning as a potent scavenger of hydroxyl radicals ( . OH), singlet oxygen, oxoheme oxidants, hydroperoxyl radicals and hypochlorous acid (HOCl) (4) , urate can also form stable 2:1 coordination complexes with ferric ions, thereby protecting against iron-catalyzed oxidations (8) .
Based upon the estimated stability constant of formation of urate-Fe 3+ complexes (K SC = 1.1 x 10 11 ) and the high concentrations of urate in human plasma (500 µM), it has been suggested that this compound may be one of the major soluble-phase iron-binding protective agents formed by man (8) . This coordination complex does not appear to support electron transport and therefore, urate inhibits iron-catalyzed oxidations (34) .
Only one enzyme, xanthine oxidoreductase, is capable of producing uric acid. This enzyme physiologically uses NAD + as the electron acceptor, but can be converted from this xanthine dehydrogenase (XDH, EC 1.1.1.204) form to xanthine oxidase (XO, EC 1.1.3.22), which transfers reducing equivalents to molecular oxygen (6) . As a result of its ability to generate reactive oxygen species, the XO form has received considerable attention as a pathophysiologic cause of ischemia-reperfusion injury (18) , renal failure (35) , lipopolysaccharide-induced endothelial injury (41) , viral pneumonia (1) and cutaneous photosensitivity to hematoporphyrins (3) . Invoking a novel mechanism to explain the protection 2 of deferoxamine against XO-dependent injury by lipopolysaccharide to bovine pulmonary artery endothelial cells, Rinaldo and Gorry reported that this iron chelator inhibited the activity of both XO and xanthine dehydrogenase when added to cultured cells but not when incubated with the enzymes ex vivo (41) . We were intrigued by this finding, and wondered if the converse might be true: Would increased iron stimulate lung xanthine oxidoreductase activity? Studying whole lungs and a cultured renal cell line, we found that total xanthine oxidoreductase activity and protein levels appear to be modulated by the supply of iron provided either as a soluble salt or environmentally relevant chelate. This suggests a possible mechanism by which iron regulates urate production in direct response to local need for urate to complex transition metals and protect biologic systems from free radical injury.
3

METHODS
Materials.
The silica dust (Min-U-Sil 5) employed in these studies was obtained from U.S. Preparation of Silica Dusts. SiO 2 has a capacity to coordinate ferric ion and, through metalcatalyzed radical generation, present an oxidative stress to the lung. Therefore, silica was used in studies as it exemplifies a relevant environmental exposure to iron (12) . Fe 3+ and Zn 2+ were complexed to silica as previously described (14) . Briefly, 1 g of Min-U-Sil 5 was agitated in 50 ml of 1 N HCl for one hour, centrifuged at 1200 g, and the supernatant was removed. The dust was then agitated in 50 ml distilled water, centrifuged at 1200 g and washed with distilled water twice more to provide acid-washed silica (silica-H). Three hundred mg of acid-washed silica was added to either 50 ml of 1 mM ZnCl 2 or FeCl 3 and agitated for 30 min. This suspension was centrifuged at 1200 g and the sedimented dusts were washed in distilled water three times to provide silica dusts with surface-complexed zinc (silica-Zn) or surface-complexed ferric iron (silica-Fe). Surface concentrations of iron and zinc were measured by inductively coupled plasma emission spectroscopy (ICPES) after agitating 10 mg dust in 5 ml 1 N HCl for 1 hour (14) . The concentration of zinc complexed to silica-Zn was 23.4 ± 0.9 µmoles/g dust, while that of iron associated with silica-Fe was 54.8 ± 4.3 µmoles/g dust. There was no measurable metal 4 on silica-H.
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Culture of and Experiments with V79 cells.
Chinese hamster cells (V79-4) are a kidney cell line previously used for studies of xanthine oxidoreductase activity (22) . These cells were grown on Joklik's Minimum Essential Medium modified for spinner investigation (S-MEM) and supplemented with 10% fetal bovine serum. Initially, 10 8 cells were placed into 100 ml medium in an air sealed glass spinner flask (Bellco Glass Inc., Vineland, NJ). Cells grew in clumps and were split daily by letting clumps settle out, removing single cells, and adding fresh medium.
Cells were maintained at a density which required only daily splitting (approximately 10 6 cells per ml). The volume of medium was increased with each split until the desired cell density was reached.
Cells (5 x 10 7 ) in 50 ml S-MEM were incubated at 37 o C in an atmosphere of 5% CO 2 either with or without (n = 5 per treatment group) 500 µM of the XO inhibitor allopurinol, 500 µM ferric ammonium sulfate (FAS), 100 µM of the iron chelator deferoxamine, 1000 µg/ml unmodified silica, or 1000 µg/ml silica in the presence of 100 µM deferoxamine. After two hours, cell viability was determined by staining with trypan blue and quantifying dye exclusion in 200 cells. Cells were collected by centrifugation for 2 min at 200 g. Medium was aspirated and assayed for lactate dehydrogenase (LDH) activity using a commercially available kit (Sigma) modified for an autoanalyzer (Cobas Fara II centrifugal analyzer, Roche Diagnostic, Montclair, NJ). The cell pellet was then treated with 0.1% Triton X-100 and LDH activity in the lysate was measured, permitting expression of supernatant LDH activity as a percentage of total.
In identical incubations, cells were collected by centrifugation at 200 g and gently resuspended in 0.3 ml cold lysis buffer (10 mM dithiothreitol (DTT), 0.2 mM phenylmethylsulfonyl fluoride 5 (PMSF), 5 x 10 -7 g/ml leupeptin and 0.1 mM ethylenediaminetetraacetic acid (EDTA) in 50 mM potassium phosphate, pH 7.4). Cells were sonicated on ice for 10 sec using a Microson cell disrupter at maximum power in pulse mode, and cellular XO activity was measured as described below.
Similarly, 50 ml of cell suspension (5 x 10 7 cells) was incubated with either 1.0 ml S-MEM, or S-MEM containing 1000 µg acid-washed silica, silica complexed with zinc or silica complexed with iron. After two hours, cell viability was determined by trypan blue dye exclusion and measurement of LDH as described above. After identical incubations, cells were pelleted, resuspended in cold lysis buffer and sonicated. XO and total xanthine oxidoreductase activities were then determined as described below. In separate experiments, rats were intraperitoneally injected twice a week with either 1.0 ml saline or 1.0 ml ferric-nitrilotriacetic acid (NTA) equivalent to 15 mg Fe/kg body weight.
After four weeks (that time estimated to elevate concentrations in the lung), rats (n = 6/group) were anesthetized with halothane and exsanguinated. Lung tissue was assayed for non-heme iron by hydrolysis (1.00 g wet tissue:10.0 mL 3 N HCl and 10% trichloroacetic acid) at 70 o C for 24 hours. After centrifugation at 1200 g for 10 min, iron in the supernatant was measured using ICPES. Lungs were excised for determination of XO and total xanthine oxidoreductase activities. (250 to 300 g), male Sprague-Dawley rats were exposed to either saline, aluminum ammonium sulfate or FAS. After anesthesia with 2 to 5% halothane (Aldrich Chemicals, Milwaukee, WI), either 0.3 mL of normal saline, 500 M aluminum ammonium sulfate in 0.3 mL or normal saline, or 500 M FAS in 0.3 mL of normal saline was intratracheally instilled into the lungs.
Effect of Intratracheal
After two or twenty-four hours, animals (n= 6/exposure/time point) were again anesthetized with halothane, euthanized by exsanguination, and had the lungs resected for measurement of XO and total xanthine oxidoreductase activities
In separate experiments, rats (n = 4/exposure) were intratracheally instilled with either 0.3 ml saline, or 1000 µg unmodified silica, silica-H, silica-Zn or silica-Fe in 0.3 ml saline.
After 2 hours, animals were anesthetized with halothane, exsanguinated and lungs were excised for measurement of XO and total xanthine oxidoreductase activities. In experiments involving rat intratracheal instillation of silica, total lung XO activity was measured by mixing 100 µl supernatant from lung homogenate with 1 ml 50 mM potassium nm for conversion of xanthine to uric acid (31) . In later experiments involving rat intraperitoneal injection of ferric-NTA, intratracheal instillation of aluminum or FAS, and intratracheal instillation of silica-H, silica-Zn or silica-Fe, XO activity and total xanthine oxidoreductase activity were measured in supernatant from lung homogenates using this same assay. oxidase protein was purified under denaturing conditions using nickel chelated agarose and injected into rabbits for antibody production. Antibodies generated were found to recognize aldehyde oxidase and xanthine oxidoreductase but do not discriminate between oxidase and dehydrogenase forms of xanthine oxidoreductase because of the high degree of similarity between the two. This specific antibody has been employed previously (23) .
Measurement of XO and
Effect of Intratracheal Iron Salts or Silica Dusts on
To demonstrate the sensitivity of the antibody employed in immunohistochemical Sixty-day old male Sprague-Dawley rats were intratracheally instilled with either 0.3 ml normal saline, 500 µM aluminum ammonium sulfate in 0.3 ml saline or 500 µM FAS in 0.3 ml saline. After 2 and 24 hours, animals (n = 2/exposure/time point) were anesthetized with 5% halothane and exsanguinated. Lungs were excised and inflation fixed with 10% formalin for 24
hours. Thin tissue sections were floated on a protein free water bath, mounted on silane treated slides, air-dried overnight and heat fixed to stain for xanthine oxidoreductase.
In separate experiments, rats (n = 2/exposure) were intratracheally instilled with either 0.3 ml saline, or 1000 µg silica-H, silica-Zn or silica-Fe in 0.3 ml saline. After 2 hours, animals were anesthetized with halothane, exsanguinated and lungs were excised for sectioning and staining for xanthine oxidoreductase.
To stain for xanthine oxidoreductase, sections were treated with hydrogen peroxide in methanol Slot Blots for Lung XOR. Animals were intratracheally instilled with either 0.3 ml normal saline, 500 µM aluminum ammonium sulfate in 0.3 ml saline or 500 µM FAS in 0.3 ml saline.
At twenty-four hours, the animals were euthanized, the lungs excised, and the tissue homogenized. Aliquots of homogenate containing 10 g protein were vacuum slot blotted, allowed to air-dry, blocked with 5% powdered milk for 30 minutes, and then incubated with a 1:500 dilution of the antibody to XO in 5% dry milk for 2 hours. The blot was washed and incubated with horseradish peroxidase-conjugated goat anti-rabbit IgG for 1 hour. Detection was accomplished on film using enhanced chemiluminescence reagents as per manufacturer's instructions (Amersham Corporation). The negative was quantitated using a BioImage Densitometer (BioImage, Ann Arbor, MI).
Effect of Iron Salts or Silica Dusts on Levels of Uric Acid in Bronchoalveolar Lavage.
Sixty-day old male Sprague-Dawley rats were intratracheally instilled with either 0.3 ml normal saline, 500 µM aluminum ammonium sulfate in 0.3 ml saline or 500 µM FAS in 0.3 ml saline.
After 24 hours, animals (n=4/exposure/time point) were anesthetized with 5% halothane and exsanguinated. The trachea was cannulated and lungs were lavaged by instillation and withdrawal three times of a single volume (35 ml/kg body weight) of warm (37 o C) normal saline. Bronchoalveolar lavage fluid was centrifuged at 400 g for 15 min to separate cells.
Perchloric acid was then added to the supernatant to a final concentration of 3%, and samples were stored at -80 o C until assay for uric acid.
In separate experiments, rats (n = 4/exposure) were intratracheally instilled with either 0.3 ml saline, or 1000 µg silica-Zn or silica-Fe in 0.3 ml saline. After 2 hours, animals were anesthetized with halothane and exsanguinated, and lungs were lavaged as outlined for measurement of uric acid. Statistics. Data are expressed as means ± standard deviation. Differences between two groups and multiple groups were compared employing t-tests of independent means and analysis of variance, respectively, The post-hoc test used was Scheffe's. Two-tailed tests of significance were employed. Significance was assumed at p < 0.05.
Measurement of Uric
RESULTS
Experiments with V79 Cells. V79 cells contained 22 ± 3 milliunits/mg protein XO activity and 87 ± 12 milliunits/mg protein total xanthine oxidoreductase activity. This was decreased to 0 ± 0 for both XO and XDH activities when 500 µM allopurinol was added to culture medium.
Inclusion of 500 µM FAS significantly increased XO and total xanthine oxidoreductase activities ( Figure 1 ). Similar to results previously reported in bovine pulmonary artery endothelial cells (41) , deferoxamine also significantly reduced XO activity in V79 cells (Figure 1 ). Conversely, silica significantly increased XO activity in V79 cells, and stimulation of XO by silica was blocked by deferoxamine ( Figure 1 ). Unmodified silica has considerable iron attached to its surface (14) , leading us to suspect that complexed iron might be responsible for augmentation of XO activity by silica dust. This is confirmed by results in Figure 2 . Silica-Fe, but not silica-H or silica-Zn, increased activities of both XO and total xanthine oxidoreductase in V79 cells. The ratio between XO and total xanthine oxidoreductase activities was not changed by any of the silica treatments. Allopurinol, FAS, deferoxamine, unmodified silica, silica-Zn or silica-Fe 13 caused no increase in trypan blue dye exclusion or LDH release into media, but silica-H significantly increased both the percentage of cells staining for trypan blue (16.3 ± 8.8% vs. 6.2 ± 5.3% for media control, p < 0.05) and percent LDH released into media (10.9 ± 3.3% vs. 4.2 ± 1.7% for media control, p < 0.05). While cycloheximide significantly diminished elevations in XO activity following two hour exposures of V79 cells to FAS, actinomycin had no effect ( Figure 3) . Measures of total xanthine oxidoreductase were similarly decreased after cycloheximide treatment of the cells (data not shown).
Effect of Modifying Body Iron Stores on Activity of Xanthine Oxidoreductase. To further
test for an association between iron availability and xanthine oxidoreductase activity, we modified body iron stores of rats with either an iron deficient diet or by parenteral injection of an iron salt. Animals fed an iron-deprived diet had significantly reduced lung XO and total xanthine oxidoreductase activities at eight weeks compared to those on regular chow (Figure 4 ).
Rats on an iron-deprived diet had slightly lower hematocrits (37.4 ± 1.5 compared to 40.2 ± 4.0% for those on regular chow), but these values were not significantly decreased, suggesting that profound iron deficiency was not induced. In contrast, iron-loading with Fe-NTA significantly increased XO and total xanthine oxidoreductase activities in rat lung at four weeks ( Figure 5 ). Rats injected with Fe-NTA had significantly increased concentrations of non-heme iron in the lung (115 ± 17 µM) compared to saline-injected animals (80 ± 16 µM), confirming an elevated burden of the metal in this tissue. In both iron-deprivation and iron-supplementation experiments, the ratio of lung XO to total xanthine oxidoreductase activities did not significantly change.
Effect of Intratracheal Iron Salts or Silica Dusts on Activity of Lung Xanthine
Oxidoreductase. Lung XO and total xanthine oxidoreductase activities were also significantly increased 2 hr after direct injection of FAS intratracheally ( Figure 6A ), and they remained elevated at 24 hr ( Figure 6B ). Intratracheal aluminum ammonium sulfate had no effect on lung XO or total xanthine oxidoreductase activities ( Figures 6A and 6B) , and iron injection produced no significant change in the ratio of the oxidase and dehydrogenase forms of the enzyme.
As in V79 cells, unmodified silica significantly increased activity of XO in rat lungs 2 hr after intratracheal injection (45 ± 6 milliunits/g wet lung vs 20 ± 4 for saline control, p < 0.05). Figure 7 shows that XO and total xanthine oxidoreductase activities increased in rat lung at 2 hr only after intratracheal injection of silica-Fe, and not silica-H or silica-Zn, confirming that silica enhanced enzyme activity by increasing the locally available lung concentration of iron.
Effect of Intratracheal Iron Salts or Silica Dusts on In Situ Immunohistochemistry for
Lung Xanthine Oxidoreductase. Slot blots verified a sensitivity of the antibody used for immunohistochemistry toward commercially available XO (Figure 8 ). While not providing quantitative data, in situ immunohistochemistry suggested that the increase in xanthine oxidoreductase in rat lungs in response to iron salts was the result of increased levels of protein rather than simply enhanced enzymatic activity. Compared to lungs instilled with either saline ( Figure 9A ) or aluminum ammonium sulfate ( Figure 9B ), lungs demonstrated significantly increased immunoreactivity for xanthine oxidoreductase 2 hours ( Figure 9C ) and 24 hours ( Figure 9D ) after intratracheal treatment with FAS. In lungs administered either FAS or silicaFe, antibody staining was noted in alveolar epithelium, but was greatest in airway epithelium ( Figures 9C and 9D) . Similarly, silica-Fe caused markedly enhanced lung xanthine oxidoreductase staining 2 hr after intratracheal instillation, whereas immunoreactivity of lungs 15 treated with silica-H or silica-Zn was not different from saline control lungs (data not shown).
Slot Blots for Lung XOR.
Twenty-four hours after intratracheal instillation, a significant elevation in protein was evident by slot blot after exposure to FAS relative to saline (Figure 10 ).
Instillations with aluminum ammonium sulfate were not associated with a similar increased expression of XOR in the lung.
Effect of Iron Salts or Silica Dusts on Levels of Uric Acid in Bronchoalveolar Lavage.
Urate in bronchoalveolar lavage was dramatically increased after instillation of iron salts or silica-Fe. Compared to lungs instilled with either saline or aluminum ammonium sulfate, bronchoalveolar lavage urate, normalized to protein, was significantly increased 2 hours after intratracheal treatment with FAS ( Figure 11A ). Also, silica-Fe caused marked increase in normalized lavage urate concentration, whereas lavage urate from lungs treated with silica-Zn was only slightly increased from saline control lungs ( Figure 11B ).
DISCUSSION
The major finding of our studies is that iron appears to regulate the activity of lung xanthine oxidoreductase. Elevating and reducing iron concentrations increases and decreases xanthine oxidoreductase activity respectively and, as a consequence, levels of urate in lung epithelial lining fluid ( Figure 11 ). This is true whether iron is delivered as a soluble ferric salt ( Figure 9 ) or an environmentally relevant metal chelate (i.e., a silicate). Iron stimulates an increase in total oxidoreductase activity, rather than causing conversion of the dehydrogenase to the oxidase form of the enzyme, since the ratio of XO to total xanthine oxidoreductase activities does not change with iron manipulation. Regulation appears to be exerted at least in part at a translational level (Figure 3 ), so that an increase in iron within the local tissue environment results in a rapid, local increase in expression of protein levels of xanthine oxidoreductase (Figure 9 ), rather than simply enhanced enzyme activity (Figures 6 and 7) . Oscillations in intestinal XO activity have been previously reported in direct relation with dietary iron (10, 20, 27) . Low iron intake decreases and high iron intake increases intestinal XO activity (10, 20, 27) . In contrast, hepatic XO increases slightly in response to iron deficiency (27) , an effect that may be due to increased protein half-life (7). To our knowledge, no one has previously reported an increase in lung xanthine oxidoreductase activity and protein in response to iron exposure.
If a major purpose of xanthine oxidoreductase teleologically is to produce soluble urate as an iron chelator and antioxidant, a system for enhancing enzyme levels and activity directly in relation to local availability of iron would be logical and elegant. While iron is necessary for cellular growth and aerobic respiration, this metal can also catalyze formation of reactive oxygen species that pose a potentially detrimental stress to the organism (19) . Mammalian cells in general (21, 29) , and human airway epithelium in particular (11) , have adapted such an iron responsive system for increasing production of the cellular iron storage protein ferritin in response to enhanced iron in the cellular environment. Such an iron responsive system would also seem appropriate for control of production of uric acid if this purine degradation product has been evolutionarily harnessed as an antioxidant (2,4) and iron chelator (8) . This would be especially true in the oxygen-rich, lung epithelial environment. Uric acid has been shown to be abundant in bronchoalveolar lavage fluid from humans, with levels 2 to 8 fold higher in man than in rats or guinea pig (44) . Uric acid has been identified as a major antioxidant in human nasal airway secretions (37) . Human nasal epithelium contains no activity for xanthine oxidoreductase (38) . In the nose, uric acid is thought to be taken up secondarily from plasma, concentrated and secreted by nasal glands in response to events such as cholinergic stimulation (38) . This could also be true in the lung airway. Compared to studies in pulmonary endothelium, relatively few studies have been performed on XO in lung epithelium. However, XO activity has been identified in bronchoalveolar lavage fluid in mice and guinea pigs (1, 25) and in cultured alveolar epithelial cells (36) . We have identified xanthine oxidoreductase protein in airway epithelium from rat lung sections (Figure 9 ), and have found cytokine-regulated xanthine oxidoreductase mRNA and activity in BEAS-2B cells, an SV-40 transformed human bronchial epithelial cell line (data not shown). This suggests that urate could also be made and secreted locally by respiratory epithelium, regulated in response to an environmentally related increase of iron in lung airway lining fluid.
At present the mechanisms mediating an increase in xanthine oxidoreductase in response 18 to iron are unclear. Iron-mediated generation of reactive oxygen species could promote conversion of the dehydrogenase to the oxidase form of the enzyme by reversible sulfhydryl oxidation (18, 32) . However, in our studies, iron supplementation increased and iron depletion decreased total xanthine oxidoreductase activities, without changing ratios of oxidase to dehydrogenase forms of the enzyme (Figures 2, 4-7) . The reaction of iron with urate could significantly alter the availability of the latter to inhibit xanthine oxidase. This is an alternative explanation of the elevations in enzyme activity but this would not explain any increased levels Our findings have a number of implications. First, by linking xanthine oxidoreductase activity to iron availability, the lung may have evolved a control mechanism to upregulate urate production in response to increased airway concentrations of a potentially harmful metal that must be chelated and sequestered in order to protect tissues from oxidant stress. This would provide rapid production of urate to complex the iron presented to the lung airway as a consequence of the inhalation of silicates causing pneumoconioses (12) (13) (14) , coal dust (15), particulate air pollution (9, 16) and even iron complexed to humic acid-like substances abundant in cigarette smoke (17) . Organs other than the lung may also express such a control system for xanthine oxidoreductase. Local stereotactic injection of ferric iron greatly increases uric acid concentration within the substantia nigra (46) , an observation with relevance for the relationship of oxidant stress to development of Parkinson's disease. Second, if the relationship between iron presentation and xanthine oxidoreductase activity is true not only for the lung but for the organism as a whole, there are possible ramifications for the pathogenesis of gout attacks, the treatment of hyperuricemia and the prevention of gouty arthritis. Instead of simply presenting an 20 additional purine load, ingestion of red meat, long associated with gout attacks, might also promote uric acid production by offering iron in a particularly absorbable form, the porphyrin chelate. Also, population studies have shown that plasma uric acid levels rise with age, and are higher in men than women (26, 30, 43, 45) , paralleling age and sex-related differences in total body iron stores (33) . Rather than preventing generation of a remarkably beneficial iron chelator and antioxidant with allopurinol or increasing its urinary excretion with probenecid, perhaps a more rational treatment for hyperuricemia might be not only the avoidance of highly absorbable iron in red meat, but also regular voluntary donation of blood to decrease the relatively elevated body iron stores of men and post-menopausal women, thereby balancing decreased uric acid production with antioxidant needs. Figure 1 . Effect of deferoxamine and silica on XO activity in Chinese hamster V79 cells. Cells suspensions were exposed to 500 µM FAS, 100 µM deferoxamine, 1,000 µg/ml silica or deferoxamine and silica for two hours and then XO and total xanthine oxidoreductase activities measured by a sensitive fluorometric assay (14) . FAS significantly increased both XO and total xanthine oxidoreductase activities while the iron chelator deferoxamine significantly decreased both. Comparable to the iron compound, silica significantly increased enzyme activities, and the silica-induced increases were attenuated by deferoxamine.
LEGENDS FOR FIGURES
*p < 0.05 elevated compared to saline; +p < 0.05 decreased compared to silica. or silica complex with iron (silica-Fe). After two hours XO and total xanthine oxidoreductase activities were measured by a sensitive fluorometric assay (14) . SilicaFe, but not silica-H or silica-Zn, increased activities of both XO and total xanthine oxidoreductase without changing ratios between the two activities.
*p < 0.05 compared to saline. agent was removed from the two hour incubation). XO activity was measured by a sensitive fluorometric assay (14) . FAS significantly increased XO activity. Treatments with cycloheximide significantly diminished enzyme activities after iron exposure while actinomycin had no effect. 
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Lungs were lavaged 2 hours later and analyzed for urate and protein concentrations.
Bronchoalveolar lavage urate was normalized to lavage protein concentration to correct for differences due to exudation of plasma into the airway.
*p < 0.05 compared to saline. 
